Factors associated with dysglycemia and its post-surgical resolution in patients with pheochromocytomas  

作　　者：Lin Zhao Xu Meng Qiongyu Zhang Yi Zhou Ting Zhang Tao Tian Hua Fan Huadong Zhu Yecheng Liu Fang Luo Linping Wang Weixian Yang Xianliang Zhou 

机构地区：[1]Department of Cardiology,Fuwai Hospital,National Center for Cardiovascular Disease,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100037,China [2]Emergency Department,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China [3]Department of Family Medicine&Division of General Internal Medicine,Department of Medicine,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China [4]Department of Urology,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China

出　　处：《Science China(Life Sciences)》2023年第2期411-414,共4页中国科学（生命科学英文版）

基　　金：supported by the National Key Research and Development Program of China(2016YFC1300100);the CAMS Innovation Fund for Medical Sciences(2022-I2M-C&T-A-010,2022-I2MC&T-B-041);National High Level Hospital Clinical Research Funding(2022-PUMCH-D-005,2022-PUMCH-B-110)。

摘　　要：Dear Editor,Pheochromocytomas are rare neuroendocrine tumors originating from chromaffin cells in the adrenal medulla(Neumann et al., 2019). A number of case reports and small cohorts have reported the association between dysglycemia and pheochromocytomas(Elenkova et al., 2020;Khatiwada et al., 2020;Krumeich et al., 2021). However, there are few large sample studies reporting the outcomes of dysglycemia in patients with pheochromocytomas after resection.

关 键 词：PATIENTS cytoma 

分 类 号：R73[医药卫生—肿瘤]